5th Circ. Deals Biden A Loss in Medicare Drug Pricing Row
By Mark Payne · September 20, 2024, 6:11 PM EDT
A Fifth Circuit panel majority said that a healthcare trade association has standing to challenge the Biden administration's Medicare drug pricing program, allowing the group to sidestep agency administrative procedure and...
To view the full article, register now.